Adverse drug reactions: definitions, diagnosis, and management.
By I. R. Edwards, Jeffrey Aronson. The Lancet, 2000
2,833 citations recorded by the source corpus.
Subfields: Pediatrics, Perinatology and Child Health, Pharmacology, Toxicology
View Paper: https://www.semanticscholar.org/paper/4bdaf5c03c6844cff848c5cba606f365a886fa14
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pediatrics, Perinatology and Child Health
In Pharmacology
Citations in the corpus
- High rates of adverse drug events in a highly computerized hospital. (2005, neutral): “Diuretics (n = 87), in 18% of ADEs 7 (8)‡ 13 (15) 24 (28) 38 (44)‡ 5 (6) 31 (36)”
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies (2009, methodology): “Algorithms for causality assessment have been developed (Karch & Lasagna, 1977; Edwards & Aronson, 2000).”
- Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting (2004, background): “Adverse drug reaction Harm directly caused by a drug at normal doses† (16) Unexpected adverse drug reaction: An adverse drug event whose nature or severity is not consistent with the product information (17) Congestive heart failure from metoprolol”
- A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. (2011, background): “For instance for drugs, the World Health Organization classifies adverse drug reaction in dose related, non-dose-related, time-related and dose-related, and time-related (Edwards & Aronson, 2000).”
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes (2009, methodology): “For the purposes of this study, an ADR was defined according to the definition of Edwards and Aronson [12].”
- Mine Your Own Business: Market-Structure Surveillance Through Text Mining (2012, background): “Accordingly, there are several mechanisms for surveillance of ADRs both pre-and post-marketing, such as cohort and case studies, population statistics, and anecdotal reporting from journals and doctors (see Table 2 in Edwards and Aronson 2000 for a comprehensive list).”
- Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands (2009, background): “0) Insulin (18), oral antidiabetics (12), corticosteroids (3), diuretics (3)”
- Predicting in vivo drug interactions from in vitro drug discovery data (2005, background): “As a consequence, the patient has an increased risk of suffering from an adverse drug–drug interaction (DDI”
- Deep learning improves prediction of drug–drug and drug–food interactions (2018, background): “Since DeepDDI systematically suggests all possible DDI types, it was reasoned that the outputs of DeepDDI can be used to suggest unknown (1) causal mechanisms of ADEs reported for the drug pairs in the gold standard DDI dataset.”